PRIMARY CARE CLINICAL DIGEST OCTOBER 13 2023 What’s in this issue?
1. 2. 3. 4.
5. 6. 7. 8.
Immunisation Update October 13 2023 View online
Update for Primary and Community Care See here the key messages on VRE
9. •
•
Immunisation Update October 13 2023 Update for Primary and Community Care Inbox Management Webinar International Foundation for Integrated Care (IFIC) / Webinar on Improving the Lives of People Living with Dementia October 31 2023 Rights-Based Healthcare for Intersex Children and Young People and their Whānau Olanzapine Depot Injections (Zyprexa Relprevv) Supply Issue Update Respigen Brand of Salbutamol Inhaler Discontinuation Pharmac: Supply Updates for Pharmacists October 13 2023 and Updates for Pharmacists in General Practice October 2-10 2023 Top Weekend Viewing In this issue: o Measles update o Coming up … Pacific MMR campaign for 18 – 34-year-olds o Immunisation prioritisation and coordination o Webinar – Vaccinating Health Worker drop-in session next week o Vaccinating Health Worker guide and information sheet now available o Flu Form will close in CIR from November 1 o Reminder – Additional COVID-19 boosters available for eligible population o Antenatal vaccine and funding eligibility for flu o Regular reminder on collateral available on Dropbox and Bluestar This update from Te Whatu Ora covers the following: o Mpox - a reminder that the Te Whatu Ora mpox testing and treatment funding framework for primary and community care has ceased. ▪ Guidance on testing, treatment and access to mpox consultation services HealthPathways. ▪ Further information Te Whatu Ora website. ▪ Any questions, please contact covidcareinthecommunity@health.govt.nz o Personal protective equipment (PPE) Central Supply – a reminder that changes to the provision of PPE from the Te Whatu Ora Central Supply commence from October 1 2023. ▪ Product discontinuation and timings COVID-19: Personal Protective Equipment Central Supply – Te Whatu Ora Health New Zealand ▪ Any questions, please contact COVID.HealthSupplyChain@health.govt.nz
o Vancomycin Resistant Enterococci – background on the local
Inbox Management Webinar See here the flyer
International Foundation for Integrated Care (IFIC) View online Webinar on Improving the Lives of People Living with Dementia October 31 2023 View online Rights-Based Healthcare for Intersex Children and Young People and their Whānau
•
• •
•
•
Olanzapine Depot Injections (Zyprexa Relprevv) Supply Issue Update
•
• •
•
situation in Te Manawa Taki region and Te Whatu Ora national key messages / guidance for primary care. ▪ Please refer to fact sheet: Core IPC strategies for managing VRE in healthcare facilities ▪ See attached VRE national key messages for Primary Care as at July 12 2023. ▪ Any questions, please contact ipc@health.govt.nz o Community pharmacy Covid-19 anti-viral contracts. ▪ Any questions or feedback, please contact: covidcareinthecommunity@health.govt.nz GPNZ are holding a series of webinars to help general practice with: o Workforce October 18 12.30pm o Technology advancements November 8 12.30pm o Medico-legal perspectives TBC To register, go to www.gpnz.org.nz To join the IFIC international learning experience, and registration information to attend webinar on Improving the Lives of People Living with Dementia October 31 2023 can be viewed online.
Further to previous notice of Future Procurement Opportunity dated August 11 2023, Te Whatu Ora has opened the Registration of Interest (ROI) for the service components comprising the rights-based approach to healthcare for intersex children and young people, and their whānau. Preference is to obtain the ROI documents via GETS, however, if you experience difficulties with this or have any other enquiries, please contact Shirley.lammas@nzhp.health.nz With the global supply issue affecting the olanzapine depot injection (Zyprexa Relprevv), which is used in the treatment of schizophrenia, Pharmac can confirm that stock of the 300 mg and 405 mg strengths of olanzapine depot injection has arrived and has been making its way through the supply chain. The next shipment of the 405 mg strength of olanzapine depot injection is expected on October 13 and awaiting confirmation that the 300 mg will be on the same shipment. All other presentations of olanzapine are unaffected by this supply issue and remain available. Other funded antipsychotic depot injections are available: schedule listing of antipsychotic depot injections. Please see https://pharmac.govt.nz/olanzapine for further updates.
Respigen Brand of Salbutamol Inhaler Discontinuation View online Pharmac:
• • •
Supply Updates for Pharmacists October 13 2023 View online Updates for Pharmacists in General Practice October 2-10 2023 View online Top Weekend Viewing
•
Pharmac has been advised that the Respigen brand of Salbutamol is being discontinued over the next 2-3 months. View online supply issue update or Pharmac website supply issue webpage for more information. View online to see the latest information across both these updates: o New medicine notices o Supply and updated issues o Notifications o Resolved issues o Recent decisions o Open consultations o Monthly updates o Increase in the number of supply issues o Expressions of Interest for Pharmac’s Advisory Committees If you want to get lost in a couple of action movies after the last few weeks of electioneering, try these: o Reptile (Netflix) - following the murder of an estate agent, a hardened detective attempts to uncover the truth in a case where nothing is as it seems. Watch trailer o Operation Fortune: Ruse de Guerre (Neon and Prime Video) - an elite spy must track down and stop the sale of a deadly new weapons technology. Watch trailer o Molly’s Game (TVNZ+) - Molly Bloom, who runs a highstakes poker game for prominent stars and mafia, finds herself in trouble after the FBI seek interest in her profile. Watch trailer